Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 13132 Neoplasms 10477 Carcinoma, Non-Small-Cell Lung 6870 Prostatic Neoplasms 6268 Colorectal Neoplasms 5945 Lung Neoplasms 5102 Multiple Myeloma 3576 Pancreatic Neoplasms 3561 Leukemia, Myeloid, Acute 3510 Neoplasm Metastasis 3507 Carcinoma, Hepatocellular 3271 Ovarian Neoplasms 3168 Melanoma 3139 Stomach Neoplasms 3056 Lymphoma 2982 Head and Neck Neoplasms 2603 Recurrence 2556 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499 Leukemia 2362 Colonic Neoplasms 2327 Brain Neoplasms 2310 Lymphoma, Non-Hodgkin 2268 Rectal Neoplasms 2191 Uterine Cervical Neoplasms 2191 Glioblastoma 2014 Leukemia, Lymphocytic, Chronic, B-Cell 1992 Carcinoma, Renal Cell 1913 Squamous Cell Carcinoma of Head and Neck 1880 Lymphoma, Follicular 1847 Esophageal Neoplasms 1800

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Anal Cancer Metastatic × Clear all

NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡